The Lancet Global Health (Nov 2021)

Progress and barriers towards maternal and neonatal tetanus elimination in the remaining 12 countries: a systematic review

  • Nasir Yusuf, MD,
  • Azhar A Raza, MD,
  • Diana Chang-Blanc, MPH,
  • Bilal Ahmed, MBBS,
  • Tedbabe Hailegebriel, MD,
  • Richard R Luce, MD,
  • Patricia Tanifum, MD,
  • Balcha Masresha, MD,
  • Mehoundo Faton, MD,
  • Mohamed D Omer, MBBS,
  • Saadia Farrukh, MBBS,
  • Khin D Aung, MD,
  • Heather M Scobie, PhD,
  • Rania A Tohme, MD

Journal volume & issue
Vol. 9, no. 11
pp. e1610 – e1617

Abstract

Read online

Summary: This systematic review assessed the progress and barriers towards maternal and neonatal tetanus elimination in the 12 countries that are yet to achieve elimination, globally. Coverage of at least 80% (the coverage level required for elimination) was assessed among women of reproductive age for five factors: (1) at least two doses of tetanus toxoid-containing vaccine, (2) protection at birth, (3) skilled birth attendance, (4) antenatal care visits, and (5) health facility delivery. A scoping review of the literature and data from Demographic and Health Surveys and Multiple Indicator Cluster Surveys provided insights into the barriers to attaining maternal and neonatal tetanus elimination. Findings showed that none of the 12 countries attained at least 80% coverage for women of reproductive age receiving at least two doses of tetanus toxoid-containing vaccine or protection at birth according to the data from Demographic and Health Surveys or Multiple Indicator Cluster Surveys. Barriers to maternal and neonatal tetanus elimination were mostly related to health systems and socioeconomic factors. Modification to existing maternal and neonatal tetanus elimination strategies, including innovations, will be required to accelerate maternal and neonatal tetanus elimination in these countries.